These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 32135634)

  • 41. IFN-γ-tethered hydrogels enhance mesenchymal stem cell-based immunomodulation and promote tissue repair.
    García JR; Quirós M; Han WM; O'Leary MN; Cox GN; Nusrat A; García AJ
    Biomaterials; 2019 Nov; 220():119403. PubMed ID: 31401468
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interleukin-35 Gene-Modified Mesenchymal Stem Cells Protect Concanavalin A-Induced Fulminant Hepatitis by Decreasing the Interferon Gamma Level.
    Wang W; Guo H; Li H; Yan Y; Wu C; Wang X; He X; Zhao N
    Hum Gene Ther; 2018 Feb; 29(2):234-241. PubMed ID: 29054137
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of Normal Synovial Fluid and Interferon Gamma on Chondrogenic Capability and Immunomodulatory Potential Respectively on Equine Mesenchymal Stem Cells.
    Zayed M; Adair S; Dhar M
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34203758
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Down-regulation of MHC II in mesenchymal stem cells at high IFN-gamma can be partly explained by cytoplasmic retention of CIITA.
    Tang KC; Trzaska KA; Smirnov SV; Kotenko SV; Schwander SK; Ellner JJ; Rameshwar P
    J Immunol; 2008 Feb; 180(3):1826-33. PubMed ID: 18209080
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pretreatment with interferon-γ enhances the therapeutic activity of mesenchymal stromal cells in animal models of colitis.
    Duijvestein M; Wildenberg ME; Welling MM; Hennink S; Molendijk I; van Zuylen VL; Bosse T; Vos AC; de Jonge-Muller ES; Roelofs H; van der Weerd L; Verspaget HW; Fibbe WE; te Velde AA; van den Brink GR; Hommes DW
    Stem Cells; 2011 Oct; 29(10):1549-58. PubMed ID: 21898680
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Beneficial effects of human umbilical cord mesenchymal stem cell (HUCMSC) transplantation on cyclophosphamide (CTX)-induced premature ovarian failure (POF) in Tibetan miniature pigs.
    Cai J; Liang X; Sun Y; Bao S
    Transpl Immunol; 2024 Jun; 84():102051. PubMed ID: 38744348
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Preclinical Evaluation of interferon-gamma primed human Wharton's jelly-derived mesenchymal stem cells.
    Park SJ; Kim DS; Choi M; Han KH; Han JS; Yoo KH; Moon KS
    Hum Exp Toxicol; 2023; 42():9603271231171650. PubMed ID: 37092667
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MHC expression kinetics and immunogenicity of mesenchymal stromal cells after short-term IFN-gamma challenge.
    Chan WK; Lau AS; Li JC; Law HK; Lau YL; Chan GC
    Exp Hematol; 2008 Nov; 36(11):1545-55. PubMed ID: 18715686
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition of interferon-gamma-activated nuclear factor-kappa B by cyclosporin A: A possible mechanism for synergistic induction of apoptosis by interferon-gamma and cyclosporin A in gastric carcinoma cells.
    Beppu K; Morisaki T; Matsunaga H; Uchiyama A; Ihara E; Hirano K; Kanaide H; Tanaka M; Katano M
    Biochem Biophys Res Commun; 2003 Jun; 305(4):797-805. PubMed ID: 12767900
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interferon regulatory factor-1 mediates interferon-gamma-induced apoptosis in ovarian carcinoma cells.
    Kim EJ; Lee JM; Namkoong SE; Um SJ; Park JS
    J Cell Biochem; 2002; 85(2):369-80. PubMed ID: 11948692
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Investigating the protective effects of Astragalus polysaccharides on cyclophosphamide-induced bone marrow suppression in mice and bone mesenchymal stem cells.
    Wang W; Zhang K; Dai L; Hou A; Meng P; Ma J
    Mol Immunol; 2024 Jul; 171():93-104. PubMed ID: 38805892
    [TBL] [Abstract][Full Text] [Related]  

  • 52. IFN-gamma activation of mesenchymal stem cells for treatment and prevention of graft versus host disease.
    Polchert D; Sobinsky J; Douglas G; Kidd M; Moadsiri A; Reina E; Genrich K; Mehrotra S; Setty S; Smith B; Bartholomew A
    Eur J Immunol; 2008 Jun; 38(6):1745-55. PubMed ID: 18493986
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy of IFN-γ-Primed Umbilical Cord-Derived Mesenchymal Stem Cells on Temporomandibular Joint Osteoarthritis.
    Kim H; Kim Y; Yun SY; Lee BK
    Tissue Eng Regen Med; 2024 Apr; 21(3):473-486. PubMed ID: 38190096
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mesenchymal stem cells immunomodulation: The road to IFN-γ licensing and the path ahead.
    Carvalho AÉS; Sousa MRR; Alencar-Silva T; Carvalho JL; Saldanha-Araujo F
    Cytokine Growth Factor Rev; 2019 Jun; 47():32-42. PubMed ID: 31129018
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interferon-γ-Treated Mesenchymal Stem Cells Modulate the T Cell-Related Chemokines and Chemokine Receptors in an Animal Model of Experimental Autoimmune Encephalomyelitis.
    Ahmadifard R; Jafarzadeh A; Mahmoodi M; Nemati M; Rahmani M; Khorramdelazad H; Ayoobi F
    Drug Res (Stuttg); 2023 Apr; 73(4):213-223. PubMed ID: 36754055
    [TBL] [Abstract][Full Text] [Related]  

  • 56. IFN-γ promoted exosomes from mesenchymal stem cells to attenuate colitis via miR-125a and miR-125b.
    Yang R; Huang H; Cui S; Zhou Y; Zhang T; Zhou Y
    Cell Death Dis; 2020 Jul; 11(7):603. PubMed ID: 32733020
    [TBL] [Abstract][Full Text] [Related]  

  • 57. IFN-gamma and TNF-alpha differentially regulate immunomodulation by murine mesenchymal stem cells.
    English K; Barry FP; Field-Corbett CP; Mahon BP
    Immunol Lett; 2007 Jun; 110(2):91-100. PubMed ID: 17507101
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interferon-gamma induces apoptosis of lens alphaTN4-1 cells and proteasome inhibition has an antiapoptotic effect.
    Awasthi N; Wagner BJ
    Invest Ophthalmol Vis Sci; 2004 Jan; 45(1):222-9. PubMed ID: 14691177
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genetically engineered bone marrow-derived mesenchymal stem cells co-expressing IFN-γ and IL-10 inhibit hepatocellular carcinoma by modulating MAPK pathway.
    Wang H; Wang J; Shi X; Ding Y
    J BUON; 2017; 22(6):1517-1524. PubMed ID: 29332347
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunopathology in schistosomiasis is regulated by TLR2,4- and IFN-γ-activated MSC through modulating Th1/Th2 responses.
    Liu C; Zhang YS; Chen F; Wu XY; Zhang BB; Wu ZD; Lei JX
    Stem Cell Res Ther; 2020 Jun; 11(1):217. PubMed ID: 32503644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.